Mohammad Afzal
Pediatrics · Clermont, FLNPI 1669411161
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Tris Pharma Inc at 30.7% of the total. Reporting peaked in 2021 at $499 and has fallen 60.4% since, to $198 in 2025. Among pediatrics clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 80 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$513
- Takeda Pharmaceuticals U.S.A., Inc.$130
- Pfizer$111
- Supernus Pharmaceuticals, Inc.$99
- Cranial Technologies, Inc$90
- Vanda Pharmaceuticals Inc.$88
- plus $640 from 16 others
What the payments were for
- Speaking & faculty fees$503%
- Food & beverage$1,62097%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 21 | $513 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $130 |
| Pfizer | 6 | $111 |
| Supernus Pharmaceuticals, Inc. | 7 | $99 |
| Cranial Technologies, Inc | 5 | $90 |
| Vanda Pharmaceuticals Inc. | 3 | $88 |
| Ironshore Pharmaceuticals Inc. | 3 | $80 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $73 |
| GSK | 4 | $73 |
| Sanofi Pasteur Inc. | 3 | $52 |
| Eko Health, Inc. | 1 | $50 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $40 |
| AbbVie | 2 | $39 |
| Merck | 2 | $37 |
| Novartis | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Abbott | 1 | $30 |
| UCB, Inc. | 1 | $29 |
| Meridian Bioscience Inc. | 1 | $23 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Genentech USA, Inc. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$125
How this compares
$1,670 in reported general payments places this provider in the 90th percentile of 3,964 pediatrics providers in Florida.
Other pediatrics in Clermont
- Jorge Lujan-ZilbermanTampa$378K
- Bonnie SmeryageHollywood$153K
- Patricia DeanMiami$92K
- Ryan CantvilleJacksonville$87K
- Christina CanodyTampa$87K
- Sofia MirandaMiami$67K
- Jose HerreraMiami$61K
- Joanna DavisMiami$59K
- Anastasia Albanese-O'neillGainesville$42K
- Monica ShahBrandon$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.